Anthropic's life sciences plans: Mystery programs, Nobel hires, M&A and big ambition

Dario Amodei, co-founder and CEO of Anthropic (Jason Henry/Bloomberg via Getty Images) July 20, 2026 11:37 AM EDT R&DAI Un­pack­ing An­throp­ic's 100-day sprint in­to bio­phar­ma: No­bel hires, M&A and ma­jor am­bi­tion Andrew Dunn Senior Biopharma Correspondent A year ago, An­throp­ic’s life sci­ences plans were ba­si­cal­ly just a blog post by its CEO. In late 2024, Dario Amod­ei Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER